Helping Latinx cancer patients make informed decisions about genomic testing
Official title: Full Research Project 1: Testing the Efficacy of an eHealth Decision Support Tool to Help Latinx Cancer Patients Make Informed Decisions About Tumor Genomic Testing
Funded at Hunter College · NIH-10931648 · Data updated 2026-11-12
This study is testing a helpful online tool for Latinx cancer patients to make it easier for them to understand and decide about important genetic tests that can guide their treatment options and family health, all while considering their unique cultural and language needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hunter College NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 18, 2018 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $133,662 |
| NIH project number | 5U54CA221704-07 |
| Project ID | NIH-10931648 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Latinx individuals diagnosed with cancer who are considering tumor genomic testing.
✕Less likely to help
Patients who are not Latinx or those who do not have cancer may not benefit from this research.
What this research studies
This research investigates the effectiveness of an electronic health decision support tool designed specifically for Latinx cancer patients. The tool aims to enhance understanding and decision-making regarding tumor genomic testing, which can reveal important information about potential treatments and hereditary risks. By addressing barriers such as language, cultural differences, and access to healthcare, the study seeks to empower patients to make informed choices about their cancer care. The research builds on previous findings with Black cancer patients and adapts successful strategies for the Latinx community.
Why it matters
Potential benefit: If successful, this research could significantly improve the decision-making process for Latinx cancer patients, leading to better treatment outcomes and increased awareness of genetic risks.
How similar studies have gone: Previous studies have shown success in using eHealth decision support tools with Black cancer patients, indicating potential for similar positive outcomes in the Latinx population.
Where this research is happening
-
Hunter College
New York, United States Active
Researchers
- Principal investigator: Revenson, Tracey a — Hunter College
- Study coordinator: Revenson, Tracey a
Related research
Other NIH-funded projects on the same topics.
-
Couples-based motivational interviewing to reduce drug use and HIV risk in vulnerable male couples
A couples-focused program helps at-risk male couples reduce drug use and HIV risk together.
-
Gut bacteria and a key fat molecule may shape malaria severity
A small, patient-friendly study will explore how gut bacteria and a fat signaling molecule called S1P influence how severe malaria can be in children.
-
Community Outreach Core to Boost Breast Cancer Screening and Genetic Testing in Underserved Communities
A community-focused program at a college teaches and supports ways to increase breast cancer screening and genetic testing in underserved areas.
-
Cancer research training and mentorship for early-career scientists
A training program to help early-career researchers and students grow their cancer science skills through mentorship, collaboration, and professional development.
-
Planning and Evaluation Core supports cancer research partnerships
This grant funds a Planning and Evaluation Core to help a cancer research partnership track and improve how projects and resources reduce cancer burden.
-
Biostatistics and Bioinformatics Core supports cancer research data science
A specialized hub provides biostatistics, bioinformatics, and AI expertise to cancer researchers in the Philadelphia–New York City region to design better studies and analyze complex data.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.